27 May 2021 -
German healthcare investor SHS and Dutch Rubio Impact Ventures invest €5 million in Incision for international expansion and new services for its surgical platform
- Incision is rapidly expanding its platform for surgical performance and online training
- The German SHS Gesellschaft für Beteiligungsmanagement mbH and investor Rubio Impact Ventures from Amsterdam provide 5 million euros for the expansion of Incision Group’s international business
- Operating room staff and surgical residents from over 200 hospitals in more than 18 countries now use the Incision platform
On its way to becoming the world’s leading surgical performance platform, Incision is raising five million euros in capital in its series A. The new investors, the healthcare investor SHS from Tübingen, Germany and Rubio Impact Ventures from Amsterdam, see their commitment to specifically support the development of new services and the expansion of Incision’s international business.
Surgery makes up a large part of hospital budgets, but clinical outcomes and efficiency vary significantly between clinics. It is a challenging area to improve due to the limited level of standardization, variances in surgical execution, and lack of process support tools. Incision’s goal is to connect 10,000 clinics and improve 100 million operations per year. To achieve this, Incision is building a platform for surgical knowledge, supporting surgical performance and training so all clinics can achieve results at par with the top clinics in the world. Incision is currently active in 18 countries worldwide, serving over 200 hospital clients.
“We are working closely with our hospital clients worldwide to grow the Incision platform. We are launching new products with them to boost the performance of their surgical teams and adding new users every day. We are very excited to have SHS & Rubio on-board as growth investors so we can accelerate our international rollout and move faster towards our goal to connect 10,000 clinics with our platform”, says Incision CEO Ritsaart van Montfrans.
“At SHS we have been actively following the trends in the OR and evaluating a range of investment opportunities. We believe that Incision’s experienced team, its product offering, and strategy are the right ingredients to build a European Healthcare champion”, says David Wehner, Senior Investment Manager at German MedTech investor SHS. And SHS partner Dr. André Zimmermann adds: “Incision fits perfect with our investment strategy of supporting European growth companies in the healthcare sector with our SHS industry expertise and long-standing network.”
“We are excited to back the stellar Dutch team at Incision on their mission to optimize performance in the OR and reduce surgical complications. Their impact is already global in nature, and is set to scale up to 10,000 clinics worldwide“, says Eske Scavenius, Investment Director at Rubio Impact Ventures.
With its next wave of expansion to the UK, Scandinavia, Belgium and the Middle East, Incision will be growing its international footprint further. Also, a number of features will be launched, enriching the platform with new learning materials, effective workflows, and sharing of best practices to improve on-the-job performance of individuals and teams.
Incision is a platform for surgical performance and online training, founded in 2014 in Amsterdam by Prof. Dr. Theo Wiggers and various other entrepreneurial professionals, on a mission to improve surgical care. Their team of medical doctors and business professionals believes in sharing surgical skills and making high-quality surgical knowledge accessible to everyone.
Further information: www.incision.care
Press contact: Kim Taylor,
About Rubio Impact Ventures
Rubio Impact Ventures, formerly known as Social Impact Ventures, is an investment company based in Amsterdam. They support promising entrepreneurs, primarily in the Netherlands and NW EU, with growth capital and proven business tools to reach their full potential and enable them to achieve systemic change. Their investment is targeted towards 3 thematic areas: circular solutions, healthy living and people power.
Further information: www.rubio.vc
SHS Gesellschaft für Beteiligungsmanagement is based in Tuebingen, Germany, and invests in medical technology and life science companies with a focus on expansion financing, changes in shareholder structures and successor situations. SHS holds minority as well as majority interests. The company was founded in 1993 and has since gained extensive experience as an industry investor which supports the growth of its portfolio companies through a network of partnerships regarding the introduction of new products, regulatory issues or entering new markets. The SHS fund’s European based investors include pension funds, strategic investors, funds of funds, family offices, entrepreneurs and the SHS management team. The AIFM-registered company invests up to €30 million in equity capital and volumes exceeding this amount are implemented with a network of co-investors. SHS is currently investing from its fifth fund which received capital commitments of more than €130 million.
Further information: www.shs-capital.eu